News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Strategic Research Institute Release: Optimize Pipelines And Portfolios: 6th Annual Rx And Biotech Portfolio Management Conference


10/19/2005 5:12:26 PM

NEW YORK, Dec. 13 /PRNewswire/ -- What are the best ways to optimize the value of your portfolio? How can you statistically reduce the number of strategic decisions that lead to pipeline and budgetary troubles? Over the course of two days, the "6th Rx & Biotech Portfolio Management" (January 25- 26, 2005, Philadelphia, PA) you will be quickly updated on the state-of-the- art in this fast evolving field and come away with a practical perspective.

This conference series is the definitive meeting for honing decision- making skills to enhance portfolio value for pharmaceutical and biotech companies. Hear best practices and case studies on strategies for effective portfolio and project management. Presentations featured at this year's comprehensive portfolio management meeting include:

"Portfolio Optimization vs. Prioritization -- A Hypothetical Study of the Financial Cost of Strategy in a Diversified Portfolio" Richard Bayney, Vice President of Decision Analysis & Portfolio Management Johnson & Johnson Pharmaceutical Research & Development "The Portfolio Balancing Act: Integrating Strategy & Financial Valuation" Anthony Artuso, Senior Director, Strategic Planning & Decision Analysis Bristol-Myers Squibb "Elicitation of Probabilities of Success in an R&D Portfolio: An 8-Year Case Study" John Andersen, Senior Research Fellow, Decision Science Eli Lilly & Company "Technical Feasibility -- A Standardized Measure of Project Status" Claus Due Jensen& Jesper Lyng Jensen, Project Manager, Portfolio Management Lundbeck

Over the course of two days, this conference pairs the best content with high quality networking opportunities to provide the optimal forum for developing better pipelines and portfolios in the pharmaceutical and biotech industry. Join our exceptional lineup of speakers from Artemis, Biogen IDEC, Bristol-Myers Squibb, Centocor, Eli Lilly, Enrich Consulting, IMS Health, Johnson & Johnson, LEK Consulting, Lundbeck, McKinsey, Merck, Nektar Therapeutics, Pfizer, PRTM and Strategic Decisions Group for two days of knowledge sharing amongst industry leaders.

The early bird discount ends on December 20!

For a complete agenda, conference details and registration information, please visit the conference website at http://www.srinstitute.com/cs318 or call Strategic Research Institute Customer Service at (888) 666-8514. For more information, contact Christine Tse at ctse@srinstitute.com or (212) 967- 0095 ext 256. To learn about showcasing your company to industry scientists and executive-level decision makers with an exhibit booth or sponsorship package, contact Don Buford at (212) 967-0095 ext. 277 or dbuford@srinstitute.com.

Strategic Research Institute

CONTACT: Christine Tse, +1-212-967-0095, ext 256, ctse@srinstitute.com,or Don Buford, +1-212-967-0095, ext. 277, dbuford@srinstitute.com, both ofStrategic Research Institute


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES